Obstructive lung function in idiopathic pulmonary fibrosis.
作者信息
Nishiyama Osamu, Tohda Yuji
机构信息
Department of Respiratory Medicine and Allergology, Faculty of Medicine, Kinki University, Osakasayama, Osaka, Japan
Department of Respiratory Medicine and Allergology, Faculty of Medicine, Kinki University, Osakasayama, Osaka, Japan.
出版信息
Chron Respir Dis. 2016 May;13(2):206. doi: 10.1177/1479972316629964. Epub 2016 Feb 9.
Abstract
摘要
相似文献
1
Obstructive lung function in idiopathic pulmonary fibrosis.特发性肺纤维化中的阻塞性肺功能
Chron Respir Dis. 2016 May;13(2):206. doi: 10.1177/1479972316629964. Epub 2016 Feb 9.
2
Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis.1秒用力呼气容积/用力肺活量在特发性肺纤维化中的预后价值
Chron Respir Dis. 2016 Feb;13(1):40-7. doi: 10.1177/1479972315603714. Epub 2015 Sep 15.
3
Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.慢性阻塞性肺疾病患者行肺癌肺叶切除术会影响肺功能吗？一项全国性多中心研究。
J Thorac Cardiovasc Surg. 2005 Dec;130(6):1616-22. doi: 10.1016/j.jtcvs.2005.06.049.
4
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.支气管扩张剂对特发性肺纤维化患者用力肺活量测量的影响。
Respir Med. 2015 Aug;109(8):1058-62. doi: 10.1016/j.rmed.2015.06.012. Epub 2015 Jun 24.
5
Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.放射性肺气肿对特发性肺纤维化肺功能检查的影响。
Respir Med. 2013 Nov;107(11):1781-8. doi: 10.1016/j.rmed.2013.08.039. Epub 2013 Sep 3.
6
Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted.在特发性肺纤维化中，使用不同的参考值集来计算预测的FVC百分比，可能会改变抗纤维化治疗的患者资格。
Respir Med. 2016 Nov;120:131-133. doi: 10.1016/j.rmed.2016.10.007. Epub 2016 Oct 14.
7
Functional improvement in patients with idiopathic pulmonary fibrosis undergoing single lung transplantation.特发性肺纤维化患者接受单肺移植后的功能改善
J Bras Pneumol. 2015 Jul-Aug;41(4):299-304. doi: 10.1590/S1806-37132015000000057.
8
Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.在韩国人群中，使用FEV1/FEV6作为FEV1/FVC的替代指标来检测气道阻塞的截断值。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 19;11:1957-63. doi: 10.2147/COPD.S113568. eCollection 2016.
9
The dose-response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China.尿中金属与肺功能改变及限制性和阻塞性肺疾病风险的剂量反应关联：一项基于中国人群的研究。
BMJ Open. 2015 May 21;5(5):e007643. doi: 10.1136/bmjopen-2015-007643.
10
Obstructive lung disease in children with idiopathic scoliosis.特发性脊柱侧凸患儿的阻塞性肺疾病。
J Pediatr. 2015 Apr;166(4):1018-21. doi: 10.1016/j.jpeds.2014.12.070. Epub 2015 Feb 12.
引用本文的文献
1
The Effects and Possible Mechanisms of Puerarin to Treat Uterine Fibrosis Induced by Ischemia-Reperfusion Injury in Rats.葛根素对大鼠缺血再灌注损伤诱导的子宫纤维化的治疗作用及可能机制
Med Sci Monit. 2017 Jul 13;23:3404-3411. doi: 10.12659/msm.902227.
2
Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies.从微创经支气管肺活检中获取治疗性肺球体细胞。
Respir Res. 2017 Jun 30;18(1):132. doi: 10.1186/s12931-017-0611-0.
本文引用的文献
1
Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis.1秒用力呼气容积/用力肺活量在特发性肺纤维化中的预后价值
Chron Respir Dis. 2016 Feb;13(1):40-7. doi: 10.1177/1479972315603714. Epub 2015 Sep 15.
2
Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.特发性肺纤维化：诊断时功能特征的新见解
Can Respir J. 2014 May-Jun;21(3):e55-60. doi: 10.1155/2014/825606. Epub 2014 Apr 7.
3
Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.特发性肺纤维化的生存预测：评分系统与生存模型
Am J Respir Crit Care Med. 2001 Oct 1;164(7):1171-81. doi: 10.1164/ajrccm.164.7.2003140.
4
Determinants of survival in idiopathic pulmonary fibrosis.特发性肺纤维化的生存决定因素。
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):450-4. doi: 10.1164/ajrccm.149.2.8306044.
Zotero 插件